ES503805A0 - Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida - Google Patents

Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida

Info

Publication number
ES503805A0
ES503805A0 ES503805A ES503805A ES503805A0 ES 503805 A0 ES503805 A0 ES 503805A0 ES 503805 A ES503805 A ES 503805A ES 503805 A ES503805 A ES 503805A ES 503805 A0 ES503805 A0 ES 503805A0
Authority
ES
Spain
Prior art keywords
methylsulfamoil
pirrolidinyl
metoxi
alyl
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES503805A
Other languages
English (en)
Other versions
ES8301466A1 (es
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of ES8301466A1 publication Critical patent/ES8301466A1/es
Publication of ES503805A0 publication Critical patent/ES503805A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
ES503805A 1980-08-28 1981-07-09 Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida Granted ES503805A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018635A FR2489327B1 (fr) 1980-08-28 1980-08-28 N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament

Publications (2)

Publication Number Publication Date
ES8301466A1 ES8301466A1 (es) 1982-12-01
ES503805A0 true ES503805A0 (es) 1982-12-01

Family

ID=9245444

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503805A Granted ES503805A0 (es) 1980-08-28 1981-07-09 Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida

Country Status (41)

Country Link
US (2) US4405636A (es)
EP (1) EP0047207B1 (es)
JP (1) JPS5775969A (es)
KR (1) KR840002063B1 (es)
AR (1) AR226737A1 (es)
AT (1) ATE11911T1 (es)
AU (1) AU549396B2 (es)
BE (1) BE890085A (es)
BG (1) BG36931A3 (es)
CA (1) CA1168250A (es)
CH (1) CH648299A5 (es)
CS (1) CS223895B2 (es)
DD (1) DD202011A5 (es)
DE (2) DE3169052D1 (es)
DK (1) DK157845C (es)
EG (1) EG15376A (es)
ES (1) ES503805A0 (es)
FI (1) FI73207C (es)
FR (1) FR2489327B1 (es)
GB (1) GB2083033B (es)
GR (1) GR74560B (es)
HK (1) HK55989A (es)
HU (1) HU183555B (es)
IE (1) IE51357B1 (es)
IL (1) IL63217A (es)
IN (1) IN155495B (es)
IS (1) IS1213B6 (es)
IT (1) IT1171490B (es)
JO (1) JO1120B1 (es)
LU (1) LU83583A1 (es)
MA (1) MA19218A1 (es)
MX (1) MX6707E (es)
NO (1) NO155097C (es)
OA (1) OA06877A (es)
PH (1) PH19211A (es)
PL (1) PL135397B1 (es)
PT (1) PT73509B (es)
SU (1) SU1148559A3 (es)
YU (1) YU42581B (es)
ZA (1) ZA814575B (es)
ZW (1) ZW17581A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (es) * 1966-01-21 1968-05-06
US3766178A (en) * 1967-04-03 1973-10-16 Ile De France Substituted 2-arylalkyloxy benzamides
GB1364231A (en) 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (es) * 1973-09-25 1980-06-27 Ile De France
CH605793A5 (es) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative

Also Published As

Publication number Publication date
MX6707E (es) 1985-10-23
JPH0233027B2 (es) 1990-07-25
MA19218A1 (fr) 1982-04-01
GB2083033A (en) 1982-03-17
FR2489327A1 (fr) 1982-03-05
NO155097C (no) 1987-02-11
FI812506L (fi) 1982-03-01
IL63217A (en) 1985-03-31
FI73207B (fi) 1987-05-29
FI73207C (fi) 1987-09-10
DK157845C (da) 1990-07-23
DD202011A5 (de) 1983-08-24
YU42581B (en) 1988-10-31
IE811449L (en) 1982-02-28
HU183555B (en) 1984-05-28
ES8301466A1 (es) 1982-12-01
PL135397B1 (en) 1985-10-31
PT73509A (fr) 1981-09-01
IT1171490B (it) 1987-06-10
AU549396B2 (en) 1986-01-23
KR830006201A (ko) 1983-09-20
IS2654A7 (is) 1981-09-11
CH648299A5 (fr) 1985-03-15
CA1168250A (fr) 1984-05-29
DK157845B (da) 1990-02-26
DE3169052D1 (en) 1985-03-28
PT73509B (fr) 1982-10-28
DE3133768A1 (de) 1982-06-16
BE890085A (fr) 1982-02-26
SU1148559A3 (ru) 1985-03-30
AR226737A1 (es) 1982-08-13
KR840002063B1 (ko) 1984-11-09
CS223895B2 (en) 1983-11-25
LU83583A1 (fr) 1981-12-01
IT8149179A0 (it) 1981-08-26
US4550179A (en) 1985-10-29
JO1120B1 (en) 1982-07-10
ATE11911T1 (de) 1985-03-15
US4405636A (en) 1983-09-20
NO155097B (no) 1986-11-03
PL232686A1 (es) 1982-03-01
IL63217A0 (en) 1981-10-30
JPS5775969A (en) 1982-05-12
OA06877A (fr) 1983-04-30
HK55989A (en) 1989-07-21
EP0047207A1 (fr) 1982-03-10
IE51357B1 (en) 1986-12-10
BG36931A3 (en) 1985-02-15
NO812937L (no) 1982-03-01
AU7464281A (en) 1982-03-04
DK383081A (da) 1982-03-01
GB2083033B (en) 1984-02-01
YU201081A (en) 1983-10-31
IS1213B6 (is) 1986-04-02
EG15376A (en) 1986-12-30
EP0047207B1 (fr) 1985-02-20
IN155495B (es) 1985-02-09
ZA814575B (en) 1982-07-28
PH19211A (en) 1986-02-04
FR2489327B1 (fr) 1984-05-18
ZW17581A1 (en) 1981-10-21
GR74560B (es) 1984-06-29

Similar Documents

Publication Publication Date Title
ES530716A0 (es) Un procedimiento de preparacion de un derivado de carbostirilo
RO82032A (ro) Procedeu pentru prepararea cis-izocitratului de(a,2-diamino-ciclohexan)-plastina
AR230042A1 (es) Procedimiento de sintesis de 3-alquen-2-onas
ES502177A0 (es) Procedimiento de sintesis de cloroformiatos alfa-clorados
ES503491A0 (es) Un procedimiento de preparacion de metafenilendiaminas
ES503805A0 (es) Un procedimiento de sintesis de la n(1-alil-2-pirrolidinil- metil)-2-metoxi-4-amino-5-metilsulfamoil-benzamida
RO81354A (ro) Procedeu de obtinere a antibioticului macrolid tilactona
ES500478A0 (es) Un procedimiento para obtener derivados de biciclooctano
ES538592A0 (es) Un procedimiento de obtencion de imidazoquinolinas
ES505886A0 (es) Un procedimiento para obtener nuevos compuestos de beta-lac-tama
ES505714A0 (es) Un procedimiento para preparar compuestos de cefem
RO81341A2 (ro) Procedeu de obtinere a diacetilmonoximei
RO85085A2 (ro) Procedeu de obtinere a 5-amino-benzimidazol-2-onei
ES518392A0 (es) Procedimiento de obtencion de un derivado de la l-alanil-l-prolina.
RO80172A2 (ro) Procedeu de elaborare a ferotitanului
RO80830A2 (ro) Procedeu de obtinere a diantipirilpiperazinei
AR226104A1 (es) Un procedimiento de preparacion de terc-butilfenoles
RO79237A2 (ro) Procedeu de obtinere a unui polipeptid
ES496877A0 (es) Procedimiento de obtencion de un derivado de benzotiazina
ES524985A0 (es) Un procedimiento para preparar carbotioatos de androsteno
ES277051Y (es) Un dispositivo para la confeccion de un cucurucho
ES495309A0 (es) Un procedimiento para preparar un compuesto de bezamida
AR223397A1 (es) Un procedimiento para obtener la silimarina(silimarina i-i)
RO85110A2 (ro) Procedeu de obtinere a salicilonitrilului
ES514808A0 (es) Procedimiento de obtencion de un derivado de 1-ariletanol.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001